Our mission is to pioneer cutting-edge genetic technologies inspired by the mechanisms of the immune system, with the goal of developing advanced cell therapies for a broad spectrum of diseases. Leveraging the latest tools in synthetic biology—including logic gates, genetic switches, and genetic adjuvants—we strive to design programmable, precise, and safe therapeutic solutions that redefine the boundaries of personalized medicine.
Principal Researcher
Latest Publications
Cannabidiol polarizes human neutrophils toward a cancer-promoting phenotype
Front. Immunol., 25 July 2025
2025
CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens
Front. Immunol., Vol. 15.
2025
Regulatory CD4+ T cells redirected against pathogenic CD8+ T cells protect NOD mice from development of autoimmune diabetes
Frontiers in Immunology. 15:1463971
2024
Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
Front. Immunol. Sep. 4.
2023